Corteva (NYSE:CTVA) Cut to Strong Sell at Zacks Research

Posted by Brenda Bartman on Oct 9th, 2026

Zacks Research downgraded shares of Corteva (NYSE:CTVA – Free Report) from a hold rating to a strong sell rating in a research note published on Tuesday,Zacks reports.

Several other equities research analysts also recently commented on CTVA. Barclays upped their target price on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. KeyCorp raised shares of Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 price target on the stock in a research report on Wednesday. Argus reissued a “buy” rating and issued a $91.00 price target on shares of Corteva in a report on Friday, September 18th. Weiss Ratings cut shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Finally, BMO Capital Markets set a $15.00 price objective on Corteva in a research note on Friday, October 2nd. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $64.00.

Get Our Latest Report on CTVA

Corteva Trading Down 5.5%

NYSE:CTVA opened at $13.66 on Tuesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a 1-year low of $11.74 and a 1-year high of $90.97. The firm has a market capitalization of $9.12 billion, a price-to-earnings ratio of 9.05, a PEG ratio of 1.25 and a beta of 0.57. The business’s 50-day moving average price is $72.79 and its two-hundred day moving average price is $78.74.

Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the company earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts expect that Corteva will post 1.69 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.3%. The ex-dividend date was Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Hedge Funds Weigh In On Corteva

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mn Services Vermogensbeheer B.V. bought a new position in Corteva during the 3rd quarter worth about $2,373,000. Farther Finance Advisors LLC raised its stake in shares of Corteva by 45.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 18,007 shares of the company’s stock valued at $1,398,000 after purchasing an additional 5,615 shares during the period. Avidian Wealth Enterprises LLC lifted its holdings in shares of Corteva by 6.3% in the third quarter. Avidian Wealth Enterprises LLC now owns 21,874 shares of the company’s stock valued at $1,699,000 after purchasing an additional 1,306 shares in the last quarter. Valeo Financial Advisors LLC boosted its position in shares of Corteva by 18.8% during the third quarter. Valeo Financial Advisors LLC now owns 8,273 shares of the company’s stock worth $642,000 after buying an additional 1,310 shares during the period. Finally, Toth Financial Advisory Corp acquired a new position in shares of Corteva during the third quarter worth about $81,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

Positive Sentiment: KeyBanc upgraded Corteva to Overweight after the Vylor separation and set a $17 price target. The firm expects the streamlined company could achieve “meaningful” earnings growth after 2027, potentially supporting a re-rating of the shares. Corteva upgraded at KeyBanc after spinoff of Vylor
Positive Sentiment: Options activity was unusually bullish, with investors purchasing 5,408 call options—more than five times typical daily volume. This indicates increased speculative interest in a potential recovery, although options activity is not a guarantee of future performance.
Positive Sentiment: Commentator Jim Cramer said he would be comfortable building a position in Vylor, the spun-off seed business, suggesting the separation may make the higher-quality growth assets more attractive to investors. However, he remained cautious on Corteva’s crop-protection operations. Jim Cramer Sees One Stock to Own After Corteva’s Breakup
Neutral Sentiment: KeyCorp maintained an Overweight rating and a $17 target, but its analyst projected only $1.60 in FY2029 EPS. That estimate is below the current-year consensus of $2.77, highlighting uncertainty over the pace and durability of post-spinoff earnings growth.
Negative Sentiment: Zacks Research downgraded Corteva from Hold to Strong Sell, creating a significant counterweight to the KeyBanc upgrade and likely contributing to investor caution. Corteva Downgraded by Zacks Research

About Corteva

(Get Free Report)

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.